Formoterol Fumarate /Budesonide bulk supplier for pharma manufacturers

Formoterol Fumarate /Budesonide Suppliers & Bulk Manufacturers

Available Forms: Powder For Inhalation(DPI/MDI)

Available Strengths: DPI: 100 mcg Budesonide / 6 mcg Formoterol, ; MDI: 80 mcg Budesonide / 4.5 mcg Formoterol Fumarate, 160 mcg Budesonide / 4.5 mcg Formoterol Fumarate

Reference Brands: Symbicort®(US); Symbicort® Turbohaler®, DuoResp® Spiromax®(EU - various strengths available)

Category: Respiratory Disorder

Formoterol Fumarate and Budesonide Powder for Inhalation treats asthma and COPD by combining a bronchodilator and corticosteroid. Available in the US and EU as Symbicort® Turbohaler® and DuoResp® Spiromax®, it offers strengths like 160/4.5 mcg and 320/9 mcg for effective, long-term respiratory relief.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Formoterol Fumarate and Budesonide Powder for Inhalation is a trusted combination therapy for managing asthma and COPD. Widely available in the US and EU, it delivers fast-acting bronchodilation (formoterol) and anti-inflammatory control (budesonide). Marketed as Symbicort® Turbohaler®, DuoResp® Spiromax®, and generics, it comes in strengths like 160/4.5 mcg and 320/9 mcg. These dry powder inhalers provide long-term respiratory relief, reducing symptoms and preventing exacerbations. Easy to use and effective, this inhalation therapy improves lung function and enhances quality of life. Always consult your healthcare provider for appropriate dosing and device use for optimal respiratory management.

Formoterol Fumarate /Budesonide — third party manufacturing & bulk supply

Formoterol Fumarate /Budesonide is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Formoterol Fumarate /Budesonide is supplied as Powder For Inhalation(DPI/MDI) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Formoterol Fumarate /Budesonide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Formoterol Fumarate /Budesonide →

Back to Listing

Frequently Asked Questions

Formoterol / Budesonide is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It helps control and prevent symptoms such as wheezing, shortness of breath, and airway inflammation, and reduces the frequency of exacerbations.

This combination is made from formoterol fumarate dihydrate and budesonide. Formoterol is a long-acting beta-2 agonist (LABA) that relaxes airway muscles, while budesonide is a corticosteroid that reduces inflammation in the airways.

Common trade names include Symbicort (USA, EU, UK), Foracort (India), Budamate (India), and various generic brands available globally.

The original product is marketed by AstraZeneca. It is also manufactured by multiple pharmaceutical companies worldwide including Cipla, Lupin, Sun Pharma, and other generic manufacturers.

The complete generic name is formoterol fumarate dihydrate and budesonide.

Brand names include Symbicort, Foracort, Budamate, and various region-specific generic brands.

This combination is manufactured globally in countries such as the USA, UK, EU nations, India, and LATAM regions by both innovator and generic pharmaceutical companies.